Who are Elasmogen's investors?

Elasmogen's investors include Deepbridge Capital, Scottish National Investment Bank, Innovate UK, Scottish Enterprise, Scottish Investment Bank.

Where is Elasmogen headquartered?

Elasmogen is headquartered in Aberdeen, GB.

Aberdeen, GB · Founded 2016 · 5 known investors

soloMER anti-inflammatory drug designed to be delivered to specific sites in the body.

Elasmogen was founded in 2016 by Professor Caroline Barelle MBA, Professor Andy Porter FRSB, FRSE, and Dr Obinna Ubah.

Professor Caroline Barelle MBAFounder & Chief Executive Officer

Professor Andy Porter FRSB, FRSECo-founder & Chief Technical Officer

Dr Obinna UbahFounding member; Autoimmunity/Immunology Lead

Registered name: ELASMOGEN LIMITED
Company number: SC467513
Status: Active
Company type: Private limited company
Incorporated: 15 Jan 2014
Registered office: Liberty Building, Foresterhill, Aberdeen, AB25 2ZP
Nature of business (SIC): 72110 — Research and experimental development on biotechnology
Previous names: PACIFIC SHELF 1760 LIMITED (2014–2014)
Accounts: last made up to 31 Jan 2025 · next due 31 Oct 2026
Confirmation statement: last made up to 15 Jan 2026 · next due 29 Jan 2027

Source: Companies House public register · retrieved 13 Sept 2026. Contains public sector information licensed under the Open Government Licence v3.0.

What does Elasmogen do?: soloMER anti-inflammatory drug designed to be delivered to specific sites in the body.
Who founded Elasmogen?: Elasmogen was founded by Professor Caroline Barelle MBA, Professor Andy Porter FRSB, FRSE, Dr Obinna Ubah in 2016.
Who are Elasmogen's investors?: Elasmogen's investors include Deepbridge Capital, Scottish National Investment Bank, Innovate UK, Scottish Enterprise, Scottish Investment Bank.
Where is Elasmogen headquartered?: Elasmogen is headquartered in Aberdeen, GB.